课题基金 / 基金详情

Molecular mechanisms of phenotypic modulation and growth of smooth muscle cells

Molecular mechanisms of phenotypic modulation and growth of smooth muscle cells
平滑肌细胞表型调节和生长的分子机制
批准号:
09281102
负责人:
NAGAI Ryozo
金额:
$127.87万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 2000

项目摘要

项目成果

NAGAI Ryozo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of the present research was to elucidate the molecular mechanisms underlying phenotypic modulation and growth of vascular smooth muscle cells. To this end, our objective was to determine the intrinsic and external factors which affect gene expression of molecular markers in vascular smooth muscle cells, and to apply this knowledge to the development of new therapies for vascular diseases such as atherosclerosis. Studies were grouped into three main research fields ; 1) regulation of specific gene expression and transcription in smooth muscle cells and elucidation of mechanisms underlying phenotypic modulation, 2) growth factors and cell signaling pathways underlying smooth muscle cell growth and phenotypic modulation, and 3) efficient gene therapy techniques for the vasculature and atherosclerosis with a particular focus on smooth muscle genes.Research achievements during the four year research term are as follows : 1) functional characterization of transcription factors ex … More pressed in dedifferentiated smooth muscle cells : the transcriptional regulation of the smooth muscle myosin heavy chain SMemb gene which is a molecular marker of dedifferentiated smooth muscle cells was analyzed which resulted in the isolation of the transcription factor BTEB2. Analysis of BTEB2 further resulted in elucidation of its activation mechanism and mechanisms of transcriptional induction in addition to a correlative role in human coronary restenotic lesions ; 2) elucidation of transcriptional mechanisms in smooth muscle cells : transcriptional machinery involved in smooth muscle transcription, namely chromatin remodeling factors (CIA) and histone acetyltransferases (Tip60, p300) were analyzed and their roles in transcriptional activation mechanisms were elucidated ; 3) regulatory mechanisms of HB-EGF on smooth muscle cell growth ; HB-EGF was shown to be upregulated for gene expression, protein production and shedding on smooth muscle growth and chemotaxic stimuli. The HB-EGF shedding inhibitor KB-R7785 was isolated. Additionally, the role of the ADAM faimily members which are candidates for shedding enzymes were analyzed. 4) Molecular characterization of the aging suppressor gene Klotho ; The klotho gene is expressed principally in t**npotant tissues for calcium homeostasis. Klotho plays a critical role for the regulation of electrolyte metabolism. The deficiency of the klotho gene results in degradation of cells and tissues by the actibation □calpain. Importantly, the increased activation of □calpain occurs in tissues of old mice together with the downregulation of klotho gene expression. 5) Genetic knockout analysis of the functional role of calponin hl ; the calponin hl gene was knocked out in mice which showed that calponin is involved in the muscle contractile apparatus. 6) Regulation of smooth muscle cell phenotypic modulation by gene transfer : Decoy approaches against transcription factors involved in smooth muscle growth (E2F, NFKB) were done and were extended to human clinical studies. New gene transfer methods were also developed. Less
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
Nakamura T, et al.: "Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model"Gene Ther. 9・8. 488-94 (2002)
Nakamura T 等人:“使用 E2F 结合位点的顺式元件‘诱饵’的分子策略抑制猪球囊损伤冠状动脉模型中的新内膜形成”Gene Ther 9·8 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Asakura M, et al.: "Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF : metalloproteinase inhibitors as a new therapy."Nat Med. 8. 35-40 (2002)
Asakura M 等人:“通过拮抗 HB-EGF 的 ADAM12 加工来抑制心脏肥大:金属蛋白酶抑制剂作为一种新疗法。”Nat Med。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshida T, et al.: "Mediation of unusually high concentrations of 1, 25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1 alpha-hydroxylase gene."Endocrinology. 143. 683-689 (2002)
Yoshida T 等人:“通过增加肾 1 α-羟化酶基因的表达,在纯合 klotho 突变小鼠中介导异常高浓度的 1, 25-二羟基维生素 D。”内分泌学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matthew JD, et al.: "Contractile properties and proteins of smooth muscles of a calponin knockout mouse."J Physiol. 529. 811-824 (2000)
Matthew JD 等人:“钙调蛋白敲除小鼠平滑肌的收缩特性和蛋白质。”J Physiol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
42
    KLF network in chronic diseases and cancer
    • 批准号:
      22229006
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $139.28万
    • 财政年份:
      2010
    • 负责人:
      NAGAI Ryozo
    • 依托单位:
    Molecular mechanisms that control stress response and tissue remodeling by cardiometabolic and immune systems
    • 批准号:
      19209029
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.45万
    • 财政年份:
      2007
    • 负责人:
      NAGAI Ryozo
    • 依托单位:
    The systematic analysis on the diseases through the integration of the clinical data with the genomic information
    • 批准号:
      17019008
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $103.42万
    • 财政年份:
      2005
    • 负责人:
      NAGAI Ryozo
    • 依托单位:
    Molecular mechanism of organ remodeling : Gene transcription and cell-cell interaction in mesenchymal
    • 批准号:
      14104012
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $68.89万
    • 财政年份:
      2002
    • 负责人:
      NAGAI Ryozo
    • 依托单位:
    海外基金